Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases

The heparan sulfate (HS) mimic/heparanase inhibitor roneparstat (SST0001) shows antitumor activity in preclinical sarcoma models. We hypothesized that this 100% N-acetylated and glycol-split heparin could interfere with the functions of several receptor tyrosine kinases (RTK) coexpressed in sarcomas...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassinelli, Giuliana, Favini, Enrica, Dal Bo, Laura, Tortoreto, Monica, De Maglie, Marcella, Dagrada, Gianpaolo, Pilotti, Silvana, Zunino, Franco, Zaffaroni, Nadia, Lanzi, Cinzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216983/
https://www.ncbi.nlm.nih.gov/pubmed/27374103
http://dx.doi.org/10.18632/oncotarget.10292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216983/
https://www.ncbi.nlm.nih.gov/pubmed/27374103
http://dx.doi.org/10.18632/oncotarget.10292

Ejemplares similares